Introduction
============

*Datura metel* L. (Solanaceae) seeds are one of the most popular herbal medicines for the treatment of rheumatoid arthritis and convulsions ([@B14]). Although the seeds are toxic, they also have strong analgesic, anthelmintic, antioxidant, antimicrobial, antiviral, and antidiabetic activities ([@B20]; [@B8]; [@B7]; [@B1]; [@B17]). Withanolides, flavonoids, alkaloids, sesquiterpenoids, lignans, and phenolic acids are generally considered the major bioactive compounds of *D. metel* ([@B11]; [@B13]). However, there are few reports on the chemical composition of *D. metel* seeds. In previous studies, amides, indoles, sesquiterpenes, withanolides, and withanolide glucosides have been isolated from *D. metel* ([@B23], [@B24]; [@B2]), but the constituents responsible for the treatment of different conditions have not been clarified.

It is well known that the *in vivo* metabolites of herbal medicines may play a substantial role in the therapeutics. Therefore, metabolites' identification is critical for elucidating the bioactivities of complex herbal medicines. Recently, we studied the metabolism of two typological components, including two amides (*n*-trans-feruloyltyramine and cannabisin F) and two withanolide glucosides (daturataturin A and daturametelin I) of *D. metel* seeds in rats ([@B21]). To fully predict and identify their metabolites, we selected seven main types of representative compounds from the seeds.

In this study, we aimed to improve this strategy so that it can be applied to other herbal medicines. Focusing on the identification of the *in vivo* metabolites of *D. metel* seed extracts after oral administration in rats, we first established the chemical fingerprint of *D. metel* seeds and identified 42 seed components ([Figure 1](#F1){ref-type="fig"}). Second, we examined the *in vivo* metabolic pathways of seven groups of metabolites with different scaffolds, which included 13 representative compounds, using quadrupole time-of-flight mass spectrometry (qTOF-MS) and liquid chromatography-tandem mass spectrometry (LC/MS/MS). Finally, a normal clinical dosage of the herbal extract was administered to rats, and several metabolites were detected based on the metabolic pathways. Following this strategy, 113 metabolites (including 42 original phytochemicals and 71 newly formed ones) were detected at a clinical dosage (0.15 g/kg) in rats.

![The three-step strategy proposed in the present study.](fphar-10-00571-g001){#F1}

Materials and Methods
=====================

Chemicals and Reagents
----------------------

The pure compounds daturametelindole B (**1**), daturametelin M (**3**), hyoscyamilactol (**5**), daturametelindole A (**9**), daturametelin L (**29**), daturametelindole D (**18**), *n*-trans-feruloyltyramine (**19**), daturametelindole C (**22**), daturametelin I (**30**), cannabisin F (**31**), daturaolone (**32**), daturataturin A (**36**), *n*-trans-p-coumaroyltyramine (**40**), and stigmasterol (**41**) were isolated from the seeds of *D. metel* by the authors. Their structures were characterized using nuclear magnetic resonance and MS ([Figure 2](#F2){ref-type="fig"} and [Supplementary Figures S3](#DS1){ref-type="supplementary-material"}--[S22](#DS1){ref-type="supplementary-material"}; [@B21]). Dinoxin B (**10**), withametelin L (**13**), and cinerolide (**20**) were purchased from Nantong Feiyu Biological Technology Co., Ltd. (Nanjing, China). Purities were above 98% according to high-performance liquid chromatography-ultraviolet (HPLC/UV) analysis. Beta-glucuronidase (HP-2 type, containing 100,000 U β-glucuronidase and 7500 U sulfatase per milliliter), β-nicotinamide adenine dinucleotide phosphate hydrate (β-NADP), [d]{.smallcaps}-glucose 6-phosphate sodium salt (G-6-P), and glucose-6-phosphate dehydrogenase (G-6-P-DE) used in the present study were purchased from Sigma--Aldrich (St. Louis, MO, United States). Heparin was purchased from HuiShi Biochemical Reagent Co., Ltd. (Shanghai, China). De-ionized water was prepared by a Milli-Q system (Millipore, Burlington, MA, United States). Acetonitrile, methanol, and formic acid (Sigma--Aldrich) were of HPLC grade. Other reagents were of analytical grade.

![Structure of the chemical constituents of the water extract of *Datura metel* seeds (WDS).^\*^Identified by comparing with reference standards.](fphar-10-00571-g002){#F2}

Preparation of the Water Decoction of *Datura metel* Seeds (WDS)
----------------------------------------------------------------

*Datura metel* seeds were collected from the medicinal botanical garden of Heilongjiang University of Traditional Chinese Medicine. The authenticity of the sample was identified by Dr. Ruifeng Fan, Botanist, Department of Medicinal Plant, Heilongjiang University of Traditional Chinese Medicine. The voucher specimen (specimen number: 2016035) were preserved in the laboratory of Chinese Medicine Chemistry, Heilongjiang University of Traditional Chinese Medicine. The WDS was prepared by extracting 100 g of *D. metel* seeds decocted in 600 mL water three times (2.0, 2.0, 1.0 h). The decoctions were combined, filtered, and concentrated in vacuum at 50°C. The final concentration of the extract was 0.01 g/mL (crude drug per g/mL).

Animals and Drug Administration
-------------------------------

Male Sprague--Dawley rats (180--220 g) were purchased from the Laboratory Animal Center of the Second Affiliated Hospital of Harbin Medical University (Heilongjiang Province, China). The rats were kept in metabolic cages (465 mm × 300 mm × 200 mm), and the breeding room was at 25°C and 60 ± 5% relative humidity. All animals had free access to water and normal chow was provided *ad libitum* at a 12 h dark--light cycle for 3 days, and then fasted for 12 h before the experiments. The animal facilities and protocols were approved by the Animal Care and Use Committee of the Harbin Medical University. All procedures were in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals ([@B100]).

The pure compounds, including **1**, **3**, **5**, **9**, **10**, **13**, **18**, **20**, **22**, **29**, **32**, **40**, and **41**, were suspended in 1% carboxy-methyl cellulose-sodium and were separately provided to rats (*n* = 4) orally at 20 mg/kg. The WDS was provided to rats (*n* = 4) at 0.5 g/kg (clinical dosage, equivalent to 600 mg/day for a 60-kg human), respectively. The dosage in our study was the clinically safe and effective ([@B15]). The control group (*n* = 4) was administrated with 1000 μL normal saline.

Preparation of Plasma, Urine, and Fecal Samples
-----------------------------------------------

To obtain plasma samples, blood (1000 μL) was collected from the angular vein into heparinized tubes at six time points: 0.5, 1, 2, 4, 6, and 10 h after the administration of WDS and pure compounds (*n* = 4). The blood of two rats was collected at 0.5, 2, and 6 h, or at 1, 4, and 10 h, and then centrifuged at 10,000 × *g* for 10 min at 4°C to obtain the plasma and then pooled plasma samples of different time points. Urine and fecal samples were collected for 0--24 h from rats held in metabolic cages (DXL-D, Keke Medical Model Co., Ltd., Shanghai, China).

Plasma, urine, and fecal samples were prepared as described in our previous report ([@B21]). The residue of these samples was dissolved in 300 μL of methanol, and filtered through a 0.22-μm membrane for ultra-high performance liquid chromatography coupled with electrospray ionization (UPLC/ESI) qTOF-MS analysis.

Incubation of Rat Liver Microsomes
----------------------------------

Compounds **3**, **5**, **10**, **13**, **29**, **40**, and **41** were separately dissolved in methanol, and then diluted with phosphate buffered saline (PBS). The final concentration of each compound in the 200-μL incubation mixture (NADPH-generating system, 100 mM potassium phosphate buffer (pH 7.4), and rat liver microsomes) was 25 μM, and the amount of organic solvent in the mixture was lower than 1% (v/v). PBS-containing methanol was added as the negative control. The incubation was conducted at 37°C for 2 h. After this period, the reaction was terminated by adding 1000 μL of cold acetonitrile. The mixture was then kept at 4°C for 30 min, and the precipitated protein was removed by centrifugation at 10,000 × *g* for 10 min at 4°C.

Enzyme Hydrolysis
-----------------

A 100-μL aliquot of plasma or urine sample was dried under a gentle flow of nitrogen gas and then mixed with 400 μL of b-glucuronidase solution (containing 19.86 U/μL, in sodium acetate buffer, pH 5.5). The mixture was vortexed for 5 min, incubated in a 37°C water bath for 1.5 h, treated with 1000 μL of cold methanol--acetonitrile (1:1, v/v) to precipitate the protein, and then centrifuged at 10,000 × *g* for 10 min at 4°C. The supernatant was dried under a gentle nitrogen flow and then dissolved in 100 μL of methanol. The solution was filtered through a 0.22-μm membrane for analysis.

UPLC/ESI/qTOF-MS Analysis
-------------------------

The analysis was performed on an ACQUITY UPLC instrument coupled with a Xevo G2 qTOF mass spectrometer (Waters, Milford, MA, United States) via an ESI ion source. The autosampler was controlled via the MassLynx^TM^ 4.1 software (Waters). Samples were separated on an ACQUITY UPLC HSS T3 column (2.1 mm × 100 mm, 1.7 μm; Waters). The mobile phase consisted of acetonitrile (A) and water containing 0.1% (v/v) formic acid (B) at a flow rate of 400 μL/min. The gradient elution program was set as follows: 0--7 min, 10--22% A; 7--13 min, 22--70% A; 13--17 min, 70--90% A; 17--20 min, 90--95% A; 20--22 min, 95% A. A 2-μL sample aliquot was injected for analysis, and the column temperature was 40°C.

The qTOF/MS system was equipped with an ESI source operating in positive ion mode, as in our previous report ([@B21]). High-purity nitrogen (N~2~) and high-purity helium (He) were used as desolvation gas and collision gas, respectively. The flow rate of N~2~ was 600 L/h and that of He was 50 L/h. The optimized parameters were: capillary voltage, 3.5 kV; sample cone voltage, 30 V; and extraction cone voltage, 4 V. The desolvation and source temperatures were 350°C and 100°C, respectively. The MS full scan range was 100--1000 *m*/*z*, and MS^n^ range was 100--800 *m*/*z*. All data collected in the positive ion mode were acquired and processed by the MassLynx^TM^ 4.1 software (Waters). UHPLC/qTOF-MS is the high-resolution mass spectra, which could provide the accurate \[M+H\]^+^ ions of the metabolites.

Quadrupole Ion Trap (Q TRAP) LC/MS/MS
-------------------------------------

The AB SCIEX 4000 Q TRAP^TM^ composite triple quadrupole/linear ion trap tandem mass spectrometer (SCIEX, Framingham, MA, United States) connected to the UHPLC via the ESI interface (Applied Biosystems, Foster City, CA, United States) was operated in the positive ion mode. The column effluent was split using a zerodead-volume "T" connector, with approximately half of the flow being fed to the mass spectrometer. The interface and parameters of the mass spectrometer were as follows: spray capillary voltage, 5.5 kV; DP, 70 V; EP, 0 V; CE, 45 V; nebulizer pressure, 40 psi; dry gas pressure, 40 psi; curtain gas pressure, 10 psi; and dry gas temperature, 600°C. All data were acquired and processed using Analyst (SCIEX). The mass spectrum fragment ions of MS^2^ and MS^3^ could be obtained by Q-TRAP LC/MS/MS.

Results and Discussion
======================

Characterization of the Chemical Constituents of WDS
----------------------------------------------------

A rapid and sensitive UHPLC/qTOF-MS method was employed to characterize the chemical constituents of WDS. Forty-two compounds (**1--42**) were identified or tentatively characterized ([Figure 3](#F3){ref-type="fig"}), including 18 withanolides, 14 withanolide glucosides, six amides, one indole, one triterpenoid, one steroid, and one sesquiterpenoid. Among them, 17 compounds (**1**, **3**, **5**, **9**, **10**, **13**, **18**, **19**, **20**, **22**, **29**, **30**, **31**, **32**, **36**, **40**, and **41**) were unambiguously identified by a comparison with reference standards. Another 25 potential constituents (**2**, **4**, **6**, **7**, **8**, **11**, **12**, **14**, **15**, **16**, **17**, **21**, **23**, **24**, **25**, **26**, **27**, **28**, **33**, **34**, **35**, **37**, **38**, **39**, and **42**) were tentatively characterized based on their retention times, UV spectra, high-accuracy mass spectra, and MS/MS fragmentation behaviors. Chemical structures of the single compounds characterized in WDS are given in [Figure 2](#F2){ref-type="fig"}.

![LC/MS total ion currents of the water extract of *Datura metel* seeds (WDS). ^\*^Identified by comparing with reference standards.](fphar-10-00571-g003){#F3}

Metabolic Pathways of Single Representative Compounds
-----------------------------------------------------

The chemical constituents of WDS were classified into seven groups according to their structural type: withanolides (A), withanolide glucosides (B), amides (C), indoles (D), triterpenoids (E), steroids (F), and sesquiterpenoids (G). In our previous study, we selected four representative compounds containing two withanolide glucosides (daturataturin A and daturametelin I), and two amides (cannabisin F and *n*-trans-feruloyltyramine) from WDS and elucidated their metabolic pathways ([@B21]). In the present study, we used these pathways for metabolite identification of other compounds, which had similar scaffolds in WDS, developing a "compound to extract" strategy. The metabolic pathways of daturametelindole B (**1**), daturametelin M (**3**), hyoscyamilactol (**5**), daturametelindole A (**9**), dinoxin B (**10**), withametelin L (**13**), daturametelindole D (**18**), cinerolide (**20**), daturametelindole C (**22**), daturametelin L (**29**), daturaolone (**32**), *n*-trans-p-coumaroyltyramine (**40**), and stigmasterol (**41**) were first reported in this study, and these 13 single compounds were selected to represent seven major scaffolds in WDS. These compounds were labeled in the HPLC fingerprint of WDS. As shown in [Table 1](#T1){ref-type="table"}, the multistage mass spectrum fragmentation information (ESI-MS^n^) was obtained both from UPLC/ESI/qTOF-MS and Q TRAP LC/MS/MS analysis.

###### 

Characterization of *in vivo* metabolites of *Datura metel* seeds by UPLC/ESI/qTOF-MS and Q-Trap LC/MS/MS in this study.

  **No.**         **RT**   **Formula**            **HR-MS \[M+H\]^+^**   **(+)ESI-MS^n^(*m*/*z*)**   **Metabolic Reaction**   **Plasma**                          **Urine**                       **Feces**             
  --------------- -------- ---------------------- ---------------------- --------------------------- ------------------------ ----------------------------------- ------------------------------- ----------- ---- ---- ------------
  **^\*^1**       4.32     C~14~H~14~N~2~O~3~     259.1072               259.1077                    1.9                      MS^2^\[259\]: 240,162,150,114       Daturametelindole B             --          --   \+   D^S^,D^W^
  ^a^ 1-M1        3.17     C~20~H~22~N~2~O~9~     453.1405               453.1398                    --1.5                    MS^2^\[453\]: 340,150               +GluA                           \+          ++   ++   D^S^,D^W^
                                                                                                                              MS^3^\[150\]: 114                                                                         
  1-M2            3.68     C~14~H~14~N~2~O~6~S    339.0652               339.0645                    --2.1                    MS^2^\[339\]: 321,150               +Sul                            ++          \+   --   D^S^,D^W^
                                                                                                                              MS^3^\[150\]: 122,114                                                                     
  1-M3            5.28     C~14~H~12~N~2~O~3~     257.0913               257.0921                    3.1                      MS^2^\[257\]: 150,136,122           −2H                             --          \+   --   D^S^
  **2**           4.48     C~28~H~36~O~4~         437.2689               437.2686                    --0.7                    MS^2^\[437\]: 283,258,240,150       Paraminabeolide A               \+          \+   --   D^W^
  **^\*^3**       4.52     C~28~H~42~O~6~         475.3022               475.3054                    6.7                      MS^2^\[475\]: 305,135,170           Daturametelins M                \+          \+   --   D^S^,D^W^
  3-M1            4.03     C~28~H~40~O~5~         457.2956               457.2949                    --1.5                    MS^2^\[457\]: 287,163,149           -H~2~O                          \+          \+   ++   D^S^,D^W^
  3-M2            4.24     C~28~H~44~O~8~         509.3112               509.3109                    --0.6                    MS^2^\[509\]: 340,136               +H~2~O+OH                       \+          \+   ++   D^S^,D^W^
  3-M3            4.36     C~28~H~42~O~7~         491.3001               491.3003                    --0.4                    MS^2^\[491\]: 323,155,135           +OH                             \+          \+   --   D^S^,D^W^
  3-M4            4.42     C~29~H~44~O~6~         489.3229               489.3212                    --3.4                    MS^2^\[489\]: 319,136               +CH~3~                          --          \+   \+   D^S^
  **4**           4.54     C~34~H~48~O~11~        633.3274               633.3269                    --0.8                    MS^2^\[633\]: 469,453,203,150       Baimantuoluoside C              \+          --   --   D^W^
  4-M1            3.69     C~33~H~46~O~14~S       699.2673               699.2681                    1.1                      MS^2^\[699\]: 619,455               +Sul-CH~3~                      \+          \+   --   D^W^
                                                                                                                              MS^3^\[455\]: 273,187,163,136                                                             
  4-M2            4.18     C~34~H~46~O~11~        631.3119               631.3113                    --1.0                    MS^2^\[631\]: 467,288,136           −2H                             --          ++   --   D^W^
  4-M3            4.35     C~40~H~56~O~17~        809.3598               809.3590                    --0.9                    MS^2^\[809\]: 633,469,295,136       +GluA                           --          ++   --   D^W^
  **^\*^5**       4.60     C~28~H~40~O~6~         473.2887               473.2898                    2.3                      MS^2^\[473\]: 301,206,171           Hyoscyamilactol                 \+          \+   ++   D^S^,D^W^
  5-M1            4.13     C~28~H~40~O~7~         489.2838               489.2847                    1.8                      MS^2^\[489\]: 338,317,171,135       +OH                             ++          \+   \+   D^S^,D^W^
  **6**           5.38     C~30~H~39~ClO~8~       563.2412               563.2406                    --1.0                    MS^2^\[563\]: 409,393,260,153       Physagulin I                    \+          \+   \+   D^W^
  6-M1            4.31     C~30~H~39~ClO~11~S     643.1985               643.1974                    --1.7                    MS^2^\[643\]: 563,409,164           +Sul                            --          \+   \+   D^W^
  6-M2            4.95     C~36~H~45~ClO~14~      737.2583               737.2571                    --1.6                    MS^2^\[737\]: 561,407,150           +GluA-2H                        --          --   \+   D^W^
  **7**           5.86     C~30~H~42~O~9~         547.2879               547.2902                    4.2                      MS^2^\[547\]: 393,240,153,114       Physagulin K                    --          \+   \+   D^W^
  **8**           5.92     C~34~H~50~O~12~        651.3371               651.3375                    0.6                      MS^2^\[651\]: 487,319,288,163       Coagulin L                      \+          \+   --   D^W^
  **^\*^9**       6.12     C~14~H~14~N~2~O~2~     243.1116               243.1128                    4.9                      MS^2^\[243\]: 215,187,107           Daturametelindole A             \+          \+   \+   D^S^,D^W^
  ^a^ 9-M1        2.75     C~20~H~20~N~2~O~8~     417.1297               417.1292                    --1.2                    MS^2^\[417\]: 241,150,134           +GluA-2H                        --          --   ++   D^S^,D^W^
  ^a^ 9-M2        4.69     C~20~H~22~N~2~O~9~     435.1388               435.1398                    2.3                      MS^2^\[435\]: 259,231,136           +GluA+OH                        ++          \+   --   D^S^,D^W^
  9-M3            5.28     C~15~H~16~N~2~O~2~     257.1296               257.1285                    --4.2                    MS^2^\[257\]: 243,215,136,107       +CH~3~                          \+          \+   ++   D^S^,D^W^
  ^a^ 9-M4        5.82     C~20~H~22~N~2~O~11~S   499.1002               499.1017                    3.0                      MS^2^\[499\]: 419,243,150           +GluA+Sul                       \+          \+   --   D^S^,D^W^
  9-M5            6.49     C~13~H~12~N~2~O~5~S    309.0532               309.0540                    2.5                      MS^2^\[309\]: 229,136,122           +Sul-CH~3~                      ++          \+   --   D^S^,D^W^
  9-M6            6.68     C~14~H~14~N~2~O~6~S    339.0652               339.0645                    --2.0                    MS^2^\[339\]: 259,243,215           +Sul+OH                         ++          ++   --   D^S^,D^W^
  **^\*^10**      7.52     C~34~H~48~O~11~        633.3244               633.3269                    3.9                      MS^2^\[633\]: 469,437               Dinoxin B                       \+          ++   \+   D^s^, D^w^
                                                                                                                              MS^3^\[469\]: 285,136                                                                     
  10-M1           5.88     C~34~H~48~O~12~        649.3251               649.3219                    --4.9                    MS^2^\[649\]: 483,299,136           +OH                             \+          ++   \+   D^S^,D^W^
  10-M2           6.03     C~35~H~50~O~11~        647.3442               647.3426                    --2.4                    MS^2^\[647\]: 483,471,285           +CH~3~                          \+          \+   ++   D^S^,D^W^
  ^a^ 10-M3       7.06     C~40~H~56~O~17~        809.3586               809.3590                    0.5                      MS^2^\[809\]: 437,469,246,136       +GluA                           \+          ++   ++   D^S^,D^W^
  10-M4           8.44     C~34~H~46~O~11~        631.3132               631.3113                    --3.0                    MS^2^\[632\]: 467,421,228,114       -2H                             \+          \+   \+   D^S^,D^W^
  10-M5           9.78     C~28~H~35~O~6~         468.2533               468.2506                    --5.7                    MS^2^\[468\]: 283,134               -Glc-2H                         --          \+   \+   D^S^,D^W^
  **11**          8.14     C~28~H~38~O~5~         455.2799               455.2792                    --1.5                    MS^2^\[455\]: 287,167,152,135       Withawrightolide                --          --   \+   D^W^
  **12**          8.36     C~38~H~54~O~15~        751.3517               751.3535                    2.3                      MS^2^\[751\]: 589,419,331,193       Chantriolide C                  --          --   \+   D^W^
  12-M1           8.51     C~44~H~62~O~21~        927.3855               927.3856                    0.1                      MS^2^\[927\]: 751,589,419           +GluA                           --          --   ++   D^w^
                                                                                                                              MS^3^\[419\]: 331,193,155,134                                                             
  12-M2           7.58     C~37~H~52~O~18~S       817.2951               817.2947                    --0.5                    MS^2^\[817\]: 737,575,405,193       +Sul-CH~3~                      --          --   \+   D^W^
  12-M3           7.62     C~38~H~56~O~17~        785.3573               785.3590                    2.1                      MS^2^\[785\]: 391,357,193,163       +OH+H~2~O                       --          --   ++   D^W^
  12-M4           8.00     C~39~H~56~O~16~        781.3628               781.3641                    1.6                      MS^2^\[781\]: 391,373,355,193,163   +OH+CH~3~                       --          --   ++   D^W^
  12-M5           14.98    C~38~H~52~O~15~        749.3361               749.3379                    2.4                      MS^2^\[749\]: 357,283,193,163       -2H                             --          --   ++   D^W^
  **^\*^13**      8.73     C~28~H~36~O~5~         453.2654               453.2636                    --3.9                    MS^2^\[453\]: 341,285,167,114       Withametelin L                  ++          ++   ++   D^S^,D^W^
  13-M1           7.74     C~27~H~34~O~8~S        519.2055               519.2047                    --1.5                    MS^2^\[519\]: 439,271,167,150       +Sul-CH~3~                      \+          \+   \+   D^S^,D^W^
  13-M2           8.19     C~28~H~36~O~6~         469.2574               469.2585                    2.3                      MS^2^\[469\]: 301,269,167           +OH                             ++          ++   ++   D^S^,D^W^
  **14**          8.91     C~34~H~52~O~10~        621.3642               621.3633                    --1.4                    MS^2^\[621\]: 509,457               Coagulin Q                      \+          \+   \+   D^w^
                                                                                                                              MS^3^\[457\]: 314,287,163,135                                                             
  **15**          9.05     C~29~H~42~O~8~         519.2957               519.2950                    --1.3                    MS^2^\[519\]: 319,295,262,199,165   Baimantuoluoline C              \+          \+   \+   D^W^
  15-M1           7.56     C~29~H~42~O~9~         535.2914               535.2902                    --2.2                    MS^2^\[535\]: 509,335,199,165       +OH                             ++          \+   \+   D^W^
  **16**          9.40     C~28~H~40~O~7~         489.2856               489.2847                    --1.8                    MS^2^\[489\]:439,317,353,171        Philadelphicalactone A          --          \+   \+   D^W^
  **17**          9.43     C~33~H~48~O~11~        621.3288               621.3269                    --3.0                    MS^2^\[621\]: 457,289,136           Withalongolide L                \+          ++   --   D^W^
  17-M1           7.37     C~33~H~48~O~14~S       701.2834               701.2838                    --0.5                    MS^2^\[701\]: 621,457,289,136       +Sul                            --          ++   ++   D^W^
  **^\*^18**      9.77     C~14~H~14~N~2~O~5~     291.0968               291.0975                    2.4                      MS^2^\[291\]: 246,219,155,135       Daturametelindole D             \+          \+   ++   D^S^,D^W^
  18-M1           7.48     C~13~H~12~N~2~O~8~S    357.0391               357.0387                    --1.1                    MS^2^\[357\]: 277,144,135           +Sul-CH~3~                      \+          \+   ++   D^S^
  18-M2           8.43     C~14~H~14~N~2~O~8~S    371.0538               371.0544                    1.6                      MS^2^\[371\]: 291,155,135           +Sul                            --          \+   ++   D^S^,D^W^
  **^\*^19**      10.86    C~18~H~19~NO~4~        314.1366               314.1387                    6.6                      MS^2^\[314\]: 314,177,163           N-trans-feruloyltyramine        --          --   ++   D^W^
  ^a^ 19-M1       8.50     C~24~H~27~NO~11~       506.1669               506.1657                    --2.3                    MS^2^\[506\]: 330,314,177,145       +GluA+OH                        ++          \+   --   D^W^
  19-M2           8.14     C~18~H~19~NO~5~        330.1339               330.1336                    --0.9                    MS^2^\[330\]: 177,137               +OH                             ++          \+   --   D^W^
  19-M3           9.65     C~18~H~17~NO~4~        312.1232               312.1230                    --0.6                    MS^2^\[312\]: 177,145,114           -2H                             ++          ++   ++   D^W^
  **^\*^20**      10.91    C~15~H~18~O~2~         231.1377               231.1380                    1.3                      MS^2^\[231\]: 215,203,190,136       Cinerolide                      \+          \+   ++   D^S^,D^W^
  ^a^ 20-M1       6.46     C~21~H~24~O~8~         405.1552               405.1544                    --1.9                    MS^2^\[405\]: 229,187,201,134       +GluA-2H                        \+          \+   --   D^S^,D^W^
  20-M2           8.60     C~15~H~18~O~5~S        311.0934               311.0948                    4.5                      MS^2^\[311\]: 231,190,136           +Sul                            ++          \+   --   D^S^,D^W^
  20-M3           9.92     C~14~H~16~O~2~         217.1211               217.1223                    5.5                      MS^2^\[217\]: 189,174               -CH~3~                          \+          \+   --   D^S^
  **21**          12.10    C~40~H~62~O~15~        783.4153               783.4161                    1.0                      MS^2^\[783\]: 457,355,325,288       Withanoside IV                  --          \+   --   D^W^
  21-M1           8.06     C~41~H~64~O~16~        813.4274               813.4267                    --0.8                    MS^2^\[814\]: 487,325,318,226,288   +OH+CH~3~                       --          ++   ++   D^W^
  **^\*^22**      12.87    C~18~H~22~N~2~O~4~     331.1660               331.1652                    --2.4                    MS^2^\[331\]: 325,223,189,107       Daturametelindole C             ++          \+   --   D^S^,D^W^
  22-M1           8.21     C~17~H~20~N~2~O~7~S    397.1068               397.1064                    --1.0                    MS^2^\[397\]: 317,209,107           +Sul-CH~3~                      ++          ++   ++   D^S^,D^W^
  22-M2           10.07    C~17~H~20~N~2~O~4~     317.1487               317.1496                    2.8                      MS^2^\[317\]: 209,150,107           -CH~3~                          ++          \+   --   D^S^,D^W^
  **23**          12.93    C~28~H~40~O~5~         457.2945               457.2949                    0.8                      MS^2^\[457\]: 285,171,151,147       Cilistol A                      --          --   \+   D^W^
  23-M1           8.96     C~34~H~48~O~11~        633.3257               633.3269                    1.9                      MS^2^\[633\]: 457,171,151           +GluA                           --          --   \+   D^W^
  **24**          13.09    C~40~H~62~O~15~        783.4154               783.4161                    0.9                      MS^2^\[783\]: 457,325,289,162       Withanoside VI                  --          --   \+   D^W^
  **25**          13.21    C~28~H~38~O~9~         519.2577               519.2589                    2.3                      MS^2^\[520\]: 349,197,137           Withangulatin B                 --          --   \+   D^W^
  **26**          13.41    C~30~H~42~O~7~         515.3018               515.3003                    --2.9                    MS^2^\[515\]: 343,329,193,171,150   Virginol C                      --          \+   \+   D^W^
  26-M1           15.29    C~36~H~50~O~14~        707.3282               707.3273                    --1.2                    MS^2^\[708\]: 532,359,193,171,166   +GluA+OH                        --          ++   ++   D^W^
  **27**          13.48    C~28~H~40~O~8~         505.2786               505.2796                    1.9                      MS^2^\[505\]: 319,264,185,136       Ajugin D                        \+          --   --   D^W^
  27-M1           10.24    C~34~H~48~O~17~S       761.2674               761.2685                    1.4                      MS^2^\[761\]: 585,505,319,185       +GluA+Sul                       --          --   ++   D^W^
  **28**          13.98    C~28~H~40~O~9~         521.2747               521.2745                    --0.4                    MS^2^\[521\]: 351,255,184,169       Phyperunolide E                 --          --   \+   D^W^
  28-M1           4.63     C~34~H~48~O~15~        697.3059               697.3066                    1.0                      MS^2^\[697\]: 521, 351,203,169      +GluA                           --          \+   --   D^W^
  28-M2           14.5     C~27~H~38~O~9~         507.2578               507.2589                    2.1                      MS^2^\[508\]: 351,184,167,155       -CH~3~                          --          \+   --   D^W^
  **^\*^29**      14.11    C~35~H~50~O~10~        631.3441               631.3477                    5.7                      MS^2^\[631\]: 566,467               Daturametelin L                 --          \+   \+   D^s^, D^w^
                                                                                                                              MS^3^\[467\]: 299,162,136                                                                 
  29-M1           9.60     C~35~H~50~O~11~        647.3439               647.3426                    --2.0                    MS^2^\[647\]: 483,469,285,135       +OH                             \+          \+   --   D^S^,D^W^
  ^a^ 29-M2       10.61    C~41~H~58~O~16~        807.3781               807.3798                    2.1                      MS^2^\[807\]: 631,453,285,135       +GluA                           --          ++   ++   D^S^,D^W^
  **^\*^**29-M3   14.93    C~34~H~48~O~10~        617.3315               617.3320                    0.8                      MS^2^\[617\]: 453,441,285,135       -CH~3~ (**30**)                 --          ++   \+   D^W^
  29-M4           15.15    C~29~H~37~O~5~         466.2720               466.2714                    --1.2                    MS^2^\[466\]: 453,285,134           -Glc-2H                         --          ++   ++   D^W^
  **^\*^30**      14.93    C~34~H~48~O~10~        617.3312               617.3320                    1.3                      MS^2^\[617\]: 453, 285,271,135      Daturametelin I                 --          ++   \+   D^W^
  ^a^ 30-M1       4.53     C~34~H~48~O~11~        633.3242               633.3269                    4.2                      MS^2^\[633\]: 469,285,136           +OH                             --          \+   \+   D^W^
  **^\*^31**      15.08    C~36~H~36~N~2~O~8~     625.2521               625.2544                    3.6                      MS^2^\[625\]:488,377,298,164,136    Cannabisin F                    --          \+   ++   D^W^
  ^a^ 31-M1       8.83     C~42~H~44~N~2~O~15~    817.2854               817.2814                    --4.8                    MS^2^\[817\]:641,611,488,373,298    +GluA+OH                        --          \+   ++   D^W^
  31-M2           9.28     C~35~H~34~N~2~O~8~     611.2368               611.2388                    3.2                      611,474,373,298,136                 -CH~3~                          \+          \+   ++   D^W^
  **^\*^32**      15.21    C~30~H~48~O~2~         441.3712               441.3727                    3.3                      MS^2^\[441\]: 423,357,150           Daturaolone                     --          --   ++   D^S^,D^W^
  ^a^ 32-M1       7.54     C~36~H~56~O~9~         633.3999               633.3997                    --0.3                    MS^2^\[633\]: 457,435,114           +GluA+OH                        \+          --   --   D^S^
  **33**          15.35    C~33~H~48~O~10~        605.3317               605.3320                    0.4                      MS^2^\[605\]: 441,273,148,138       Withalongolide M                --          --   \+   D^W^
  33-M1           7.10     C~33~H~48~O~14~S       701.2854               701.2838                    --2.2                    MS^2^\[701\]: 621,457,289,135       +Sul+OH                         ++          \+   --   D^W^
  **34**          15.39    C~28~H~42~O~9~S        555.2606               555.2622                    2.8                      MS^2^\[555\]: 357,299,150           Cilistol Y                      \+          \+   \+   D^W^
  **35**          15.53    C~34~H~56~O~11~        641.3874               641.3895                    3.2                      MS^2^\[642\]: 429,385,341,150       Cilistol J                      --          --   \+   D^W^
  **^\*^36**      15.62    C~34~H~48~O~10~        617.3315               617.3320                    0.8                      MS^2^\[617\]: 453,285,136           Daturataturin A                 --          \+   \+   D^W^
  **^\*^**36-M1   7.53     C~34~H~48~O~11~        633.3247               633.3269                    3.4                      MS^2^\[633\]: 469,285,136           +OH (**10**)                    ++          \+   \+   D^W^
  ^a^ 36-M2       7.82     C~40~H~54~O~16~        791.3451               791.3485                    4.2                      MS^2^\[791\]: 617,451,268,133       +GluA-2H                        \+          --   --   D^W^
  36-M3           9.52     C~35~H~50~O~10~        631.3496               631.3477                    --3.0                    MS^2^\[631\]: 453,299,136           +CH~3~                          \+          \+   --   D^W^
  36-M4           11.63    C~28~H~36~O~5~         453.2653               453.2636                    --3.7                    MS^2^\[454\]: 437,283,136           -Glc-2H                         \+          ++   ++   D^W^
  **37**          16.68    C~28~H~36~O~6~         469.2565               469.2585                    4.2                      MS^2^\[469\]: 316,270,153,136,122   Exodeconolide A                 \+          \+   \+   D^W^
  **38**          17.03    C~34~H~52~O~11~        637.3568               637.3582                    2.1                      MS^2^\[637\]: 457,285,185,153       Withanoside XI                  --          ++   ++   D^W^
  38-M1           8.03     C~40~H~60~O~17~        813.3912               813.3903                    --1.1                    MS^2^\[813\]: 637,457,285,185       +GluA                           ++          ++   ++   D^W^
  **39**          17.58    C~28~H~36~O~7~         485.2521               485.2534                    2.6                      MS^2^\[485\]: 315,176,169,151       20-Hydroxytubocapsanolide A     --          --   \+   D^W^
  **^\*^40**      17.74    C~17~H~17~NO~3~        284.1286               284.1281                    --1.7                    MS^2^\[284\]: 147,136,122           *n*-trans-p-coumaroyltyramine   ++          ++   ++   D^S^,D^W^
  40-M1           10.96    C~17~H~19~NO~5~        318.1358               318.1336                    --6.9                    MS^2^\[318\]: 274,230,150,114       +OH+H~2~O                       ++          ++   ++   D^S^,D^W^
  40-M2           12.93    C~17~H~17~NO~4~        300.1211               300.1230                    6.3                      MS^2^\[300\]: 152,114               +OH                             ++          \+   \+   D^S^,D^W^
  ^a^ 40-M3       13.24    C~23~H~25~NO~9~        460.1623               460.1602                    --4.5                    MS^2^\[460\]:284,136                +GluA                           \+          ++   ++   D^S^,D^W^
  40-M4           14.09    C~17~H~17~NO~6~S       364.0833               364.0849                    4.3                      MS^2^\[364\]:284,147,136            +Sul                            \+          ++   ++   D^S^,D^W^
  40-M5           16.33    C~23~H~23~NO~9~        458.1437               458.1446                    1.9                      MS^2^\[458\]: 282,147,134           +GluA-2H                        --          \+   ++   D^S^,D^W^
  **^\*^41**      18.08    C~29~H~48~O            413.3790               413.3778                    --2.9                    MS^2^\[413\]: 273,139,135           Stigmasterol                    ++          ++   --   D^S^,D^W^
  41-M1           8.74     C~29~H~48~O~2~         429.3741               429.3727                    --3.2                    MS^2^\[429\]: 289,274,139           +OH                             ++          \+   --   D^S^,D^W^
  41-M2           12.08    C~29~H~46~O~3~         443.3509               443.3520                    2.4                      MS^2^\[443\]: 289,196,153,141,135   +2OH                            \+          \+   --   D^S^,D^W^
  41-M3           13.42    C~29~H~50~O~3~S        479.3563               479.3553                    --2.0                    MS^2^\[479\]: 399,275,137           +2H+Sul                         --          \+   ++   D^S^,D^W^
  **42**          18.43    C~28~H~40~O~7~         489.2821               489.2847                    5.3                      MS^2^\[489\]: 319,169,151           Jaborosalactone VIII            \+          --   --   D^W^
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### Withanolides

Compounds **3**, **5**, and **13** were chosen as representatives of withanolides ([Figure 2](#F2){ref-type="fig"}). They were considered as bioactive constituents ([@B12]; [@B25]) and could be detected *per se* in plasma and urine samples. Hydroxylation was the major metabolic reaction for withanolides from *D. metel* ([Table 1](#T1){ref-type="table"}). In addition, compounds **3** and **5** may be metabolized into 21-OH daturametelin M and 21-OH hyoscyamilactol, respectively. This reaction was also observed for daturataturin A (**36**) and daturametelin I (**30**) in our previous study ([@B21]). However, the hydroxyl position of **13** could not be assigned due to the limited structural information. Hydroxylated products were also detected when **3**, **5**, and **13** were incubated in rat liver microsomes, indicating that the hydroxylation reaction was catalyzed by P450 enzymes ([Supplementary Figure S1](#DS1){ref-type="supplementary-material"}).

### Withanolide Glucosides

The metabolism of two withanolide glucosides, **10** and **29**, was investigated. When *O*-glycosides lose the sugar residue to produce corresponding aglycones (withanolides), dehydrogenation occurs. This reaction of interconversion was very common for withanolide glucosides. In addition, hydroxylation, (de)methylation, and glucuronidation of withanolide glucosides were also major reactions as shown in [Figures 4A,B](#F4){ref-type="fig"}. These metabolites, derived from the three withanolide glucosides, were detected in plasma, urine, and fecal samples ([Table 1](#T1){ref-type="table"}). For example, **29** produced the hydroxylated metabolite **29-M1** (*m*/*z* 647→483, 469, 299, 136), the demethylated metabolite **29-M3** (*m*/*z* 617→453, 285, 136, identified as **30**), the glucuronide-conjugated metabolite **29-M2** (*m/z* 807→631, 453, 285, 136), and hydrolyzed and dehydrogenated metabolite **29-M4** (*m/z* 466→453, 285, 134).

![The proposed metabolic pathways for compounds **9** **(C)**, **10** **(B)**, **20** **(D)**, and **29** **(A)** in rats after the oral administration of the WDS. Red bold arrows indicate major metabolites; ^\*^, compared with reference standards; U, detected in urine samples; P, detected in plasma samples; F, detected in fecal samples; RLM, detected in rat liver microsomes; Sul, sulfate; GluA, glucuronic acid residue.](fphar-10-00571-g004){#F4}

### Amides

Amides are abundant in *D. metel* seeds, and considered as characteristic components ([@B9]). Four major amides (**1**, **18**, **22**, and **40**) were chosen to examine the *in vivo* metabolism of this type of compounds. In brief, the metabolism of amides varied significantly according to the group substitutions on their backbones. For example, **1** and **40** could undertake different phase I reactions, including hydroxylation, dehydrogenation, hydroxylation, and hydration. Phase II conjugation reactions (to form glucuronides and sulfates) were common in amides ([Table 1](#T1){ref-type="table"}), but the peaks of glucuronides disappeared when the sample was treated with β-glucuronidase ([Supplementary Figure S2](#DS1){ref-type="supplementary-material"}). Amides **18** and **22** were mainly involved in demethylation and sulfation. The major metabolic reactions and metabolite distributions of these four amides are listed in [Table 1](#T1){ref-type="table"}. Plasma and urine samples mainly contained phase II metabolites and hydroxylated products, while urine samples comprised most metabolites.

### Indoles

Indole alkaloids in *D. metel* seeds are extremely important, and their distribution and metabolism have been reported in several different organisms ([@B6]; [@B19]; [@B16]; [@B26]). We chose daturametelindole A (**9**) for examining metabolic pathways. The qTOF mass spectra showed \[M+H\]^+^ ions at *m*/*z* 243.1116, consistent with the molecular formula of C~14~H~14~N~2~O~2~. In the ion trap MS^n^ spectra, the \[M+H\]^+^ ions could further add a glucuronic acid moiety (176 U), and then be dehydrogenized, hydroxylated, and sulfated to produce the corresponding ions at *m*/*z* 417 (**9-M1**), 435 (**9-M2**), and 499 (**9-M4**), respectively ([Figure 4C](#F4){ref-type="fig"}). The above conjugates were confirmed by enzyme hydrolysis. When indole **9** from the plasma sample was treated with β-glucuronidase, the peaks of **9-M1**, **9-M2**, and **9-M4** disappeared, and the peak corresponding to **9** increased remarkably ([Figure 4C](#F4){ref-type="fig"}). Thus, it could be deduced that these metabolites were glucuronides of **9**. The sulfate conjugates **9-M5** and **9-M6** were detected in plasma, urine, and fecal samples. Their MS/MS spectra were dominated by the neutral loss of 80 Da. Metabolite **9-M3** was highly abundant in fecal samples. Its high-resolution mass spectra showed an \[M+H\]^+^ ion at *m*/*z* 257.1296, corresponding to the molecular formula C~15~H~16~N~2~O~2~. In the tandem mass spectra, **9-M3** produced fragment ions at *m*/*z* 243 (\[M+H-CH~3~\]^+^), *m*/*z* 215 (\[M+H-CH~3~⋅-CO\]^+^), and *m*/*z* 107 (\[M+H-CH~3~-CO-C~7~H~9~N\]^+^), indicating that it was methylated metabolite. The metabolic pathways of **9** are illustrated in [Figure 4C](#F4){ref-type="fig"}.

### Triterpenoids, Steroids, and Sesquiterpenoids

In addition to the major structural types (A) to (D), less abundant groups of compounds were also found in WDS in previous chemical studies ([@B10]; [@B22]; [@B3]). They were taken into consideration in this study, and the representative scaffolds included triterpenoids (**32**, daturaolone), steroids (**41**, stigmasterol), and sesquiterpenoids (**20**, cinerolide). Identification of **32**, **41**, and **20** is depicted in [Table 1](#T1){ref-type="table"}.

When **32** was provided to rats, high amounts of prototype were detected in fecal samples. The methoxyl groups at C-23, -14, -29, or -30 may undergo hydroxylation, followed by glucuronide conjugation ([Table 1](#T1){ref-type="table"}; [@B18]). The phase I and phase II metabolites of **41** were also observed *in vivo* samples. Among phase I metabolites, the hydroxylation products were extensively observed. This type of reaction involved the addition of one or two hydroxyl groups to the parent drug. The phase II biotransformation was mainly sulfation, and the phase II metabolite **41-M3** was formed by a reduction reaction followed by a sulfated reaction. Most steroids were metabolized in the same way as ganoderic acid D ([@B4]). After 20 mg/kg oral administration, a large portion of **20** was metabolized. Although this compound was not observed in plasma samples, it occurred in the unchanged form in fecal samples. The UPLC/ESI/qTOF-MS analysis detected large proportions of three metabolites in plasma samples ([Table 1](#T1){ref-type="table"}). The high-resolution mass spectra of **20-M3** revealed a \[M+H\]^+^ signal at *m*/*z* 217.1211, indicating the molecular formula C~14~H~16~O~2~, corresponding to a demethylated derivative of **20**. Similar to cyperon ([@B5]), **20** presented fragment ions at *m/z* 231 (\[M+H-O\]^+^), 203 (\[M+H-CO\]^+^), and 190 (\[M+H-C~3~H~5~\]^+^) ([Figure 4D](#F4){ref-type="fig"}). Two phase II metabolites of **20** were detected, namely, glucuronide conjugate (**20-M1**) and sulfate conjugate (**20-M2**) ([Figure 4D](#F4){ref-type="fig"}), which disappeared when the sample was treated with β-glucuronidase.

Characterization of WDS Metabolites at a Clinical Dosage
--------------------------------------------------------

To mimic traditional Chinese medicine clinical use, *D. metel* seeds were cooked in water to obtain the WDS extract. The dosage of WDS provided to rats (0.15 g/kg) was equivalent to the 1.5 g/day for a 60-kg human ([@B15]). Under these conditions, 61 metabolites (including intact original compounds) were detected in rat plasma samples, 83 in urine samples, and 76 in fecal samples using qTOF-MS and LC/MS/MS. Withanolides, withanolide glucosides, and alkaloids were the major absorbed chemical components of WDS, and their oral bioavailability was as follows: withanolides \>withanolide glucosides \>amides and indoles. The contents of compounds **9**, **13**, and **20** are very high in WDS, and they could also be easily detected in WDS-administrated plasma samples. Interestingly, as shown in [Table 1](#T1){ref-type="table"} and [Figure 5](#F5){ref-type="fig"}, withanolide monoglucoside (**14**) appeared to have a better oral bioavailability than withanolide diglucoside (**24**). In addition, hydroxylation or (de)methylation was the most common reaction for withanolide glucosides. The absorption of the demethylated metabolite occurred at 7-OH (for instance **29-M3**, **30**) was easier than the prototypes (**29**); besides that, the hydroxylated metabolite at C-21 (**36-M1**, **10**) could be readily absorbed into circulation than compound *per se* (**36**) ([Figures 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}).

![Ion chromatograms of **14** and **24** **(A)**, **29-M3** (**30**), and **29** **(B)** in rat fecal samples, and of **36-M1** (**10**) and **36** **(C)** in rat urine samples after the oral administration of the WDS.](fphar-10-00571-g005){#F5}

Overall, and according to the metabolic pathways of single representative compounds, the major reactions of the WDS extract included phase II metabolism, hydroxylation, (de)methylation, and dehydrogenation. The phase II metabolites were confirmed by β-glucuronidase hydrolysis. The hydroxylation of **3**, **5**, **10**, **13**, **29**, **40**, and **41** was confirmed by rat liver microsomes incubation experiments, indicating that this hydroxylation was catalyzed by P450 enzymes. Withanolides and withanolide glucosides without a phenolic hydroxyl group at C-21 might readily undergo monohydroxylation. Compounds **9**, **10**, and **36** could add a methyl group, and compounds **20**, **21**, **28**, and **31** could lose a methyl group. Finally, five dehydrogenated metabolites (**1-M5**, **4-M2**, **10-M4**, **12-M5**, and **19-M3**) were characterized by LC/MS analysis ([Table 1](#T1){ref-type="table"}). Among the metabolic reactions described above, the phase II metabolism (glucuronidation or sulfation) was observed most commonly in the metabolism of WDS constituents.

Conclusion
==========

We propose the strategy "chemical analysis, metabolism of single representative compounds, and metabolism of the extract at the clinical dosage" to systematically characterize the *in vivo* metabolites of *D. metel* seeds. After the oral administration of *D. metel* seeds water extract to rats at a normal clinical dosage (0.15 g/kg), 113 phytochemicals (including intact original compounds) were identified or tentatively characterized by a highly sensitive LC/MS-MS method. As far as we know, this is the first report on the full metabolic profiling of the *D. metel* seeds water extract *in vivo*. This strategy could be helpful for pharmacokinetic studies of multi-component herbal products.
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